Engineers Gate Manager LP Biomarin Pharmaceutical Inc Transaction History

Engineers Gate Manager LP

$5.55 Billion
Q1 2025

A detailed history of Engineers Gate Manager LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 86,720 shares of BMRN stock, worth $5.26 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

86,720

Previous 46,164 87.85%

Holding current value

$5.26 Million

Previous $3.03 Million 102.04%

% of portfolio

0.11%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$61.25 - $72.83 $2.48 Million - $2.95 Million	40,556 Added 87.85%	86,720 $6.13 Million
Q4 2024 Feb 14, 2025	SELL	$61.93 - $70.49 $4 Million - $4.55 Million	-64,533 Reduced 58.3%	46,164 $3.03 Million
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $6.93 Million - $9.42 Million	100,401 Added 975.15%	110,697 $7.78 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $391,352 - $484,892	5,258 Added 104.37%	10,296 $847,000
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $422,234 - $498,762	5,038 New	5,038 $440,000
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $838,022 - $969,700	9,668 Added 122.24%	17,577 $1.52 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $874,855 - $1.17 Million	-9,971 Reduced 55.77%	7,909 $769,000
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $1.76 Million - $2.37 Million	-21,797 Reduced 54.94%	17,880 $1.85 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $2.16 Million - $2.55 Million	26,262 Added 195.77%	39,677 $3.36 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $958,904 - $1.17 Million	13,415 New	13,415 $1.11 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $253,960 - $323,895	-3,541 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $70,358 - $80,427	941 Added 36.19%	3,541 $274,000
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $1 Million - $1.13 Million	-13,275 Reduced 83.62%	2,600 $217,000
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $586,779 - $712,097	7,852 Added 97.87%	15,875 $1.2 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $582,550 - $723,674	8,023 New	8,023 $704,000
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $2.49 Million - $3.34 Million	-38,705 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $627,157 - $791,948	9,305 Added 31.65%	38,705 $2.61 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $2.36 Million - $2.76 Million	29,400 New	29,400 $2.52 Million

Others Institutions Holding BMRN

# of Institutions

667

Shares Held

186M

Call Options Held

1.25M

Put Options Held

992K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Biomarin Pharmaceutical Inc Transaction History